Cell and Gene Therapy Clinical Trial Market

Future Market Insights

Key Insight

The cell and gene therapy clinical trial market is projected to grow from USD 24.8 billion in 2025 to USD 208.0 billion by 2035, at a CAGR of 23.7%. Phase II will dominate with a 45.3% market share, while oncology will lead the indication segment with a 55.7% share.

August 20, 2025

Anurag Sharma

250 Pages

Cite this Report

Cell and Gene Therapy Clinical Trial Market

https://www.futuremarketinsights.com/reports/cell-and-gene-therapy-clinical-trial-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Covance Inc
ICON plc
Medpace Holdings
Parexel International Corporation

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Cell and Gene Therapy Clinical Trial Market

Key Players

Similar Industry Reports